资讯

Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...
SALES: The group's first-quarter sales should come at $13.00 billion, according to a consensus of analysts' estimates compiled by Visible Alpha. This compares with $11.83 billion the year before. In ...
Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Patients with both psoriasis and hidradenitis suppurativa had the highest overall psoriasis genetic risk score. The also had the highest overall non-human leukocyte antigen genetic risk score.
With the new manufacturing capacity, 100% of its key medicines for U.S. patients will be made in the U.S., Novartis said late ...
Icotrokinra achieved 75% complete skin clearance in adolescents with moderate to severe plaque psoriasis by week 24, indicating significant efficacy. The ICONIC-LEAD trial is the first to evaluate ...
Icotrokinra had more significant improvements than placebo for multiple skin clearance measures following 16 weeks of treatment for plaque psoriasis in adolescents and adults. Icotrokinra is ...
Indeed, I think the dose was slightly higher, given the standardly used dosing schedule: The recommended dose of COSENTYX® (secukinumab) for moderate-severe plaque psoriasis is 300 mg.† ...
EC president Ursula von der Leyen is scheduled to hold a call with the European pharmaceuticals industry. Credit: VYACHESLAV OSELEDKO via Getty Images. European Commission (EC) President Ursula von ...
Art Garfunkel is breaking the sound of silence around his experience with plaque psoriasis. The singer, one half of the folk-rock duo Simon & Garfunkel, has teamed with Sun Pharma to discuss how ...